Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Chondroitin sulfate β-1,4-N-acetylgalactosaminyltransferase-1 (ChGN-1) polymorphism: Association with progression of multiple sclerosis.
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.
Vitamin D insufficiency and chronic diseases: Hype and reality.
Multiple sclerosis: Spinal cord MRI indices correlate with outcome in MS.
Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.
Clinical profile and short-term outcomes of optic neuritis patients in India.
[New and emerging treatments for multiple sclerosis].
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity.
Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Novel insights into the development and maintenance of the blood-brain barrier.
Retraction notice: Language abilities of patients with primary progressive multiple sclerosis: A preliminary group and case investigation.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Systematic Review: The effectiveness of interventions to reduce falls and improve balance in adults with multiple sclerosis.
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients.
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
327
328
329
330
331
332
333
334
335
…
next ›
last »